Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients

• Status: Completed
• Trial end date: 2018-12-11
• Target enrollment: 0
• Participant gender: Female

Summary

A randomized, prospective trial will be offered to women admitted to the labor floors at Mount Sinai Medical Center for labor induction.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Icahn School of Medicine at Mount Sinai
• Treatments: Propranolol

Criteria

Inclusion Criteria:

• Nulliparous women undergoing induction of labor

• >37 weeks' gestational age

• Non-anomalous, singleton cephalic presenting fetus.

Exclusion Criteria:

• Multiple gestations, known fetal anomalies

• Maternal cardiac or hypertensive disease

• Chronic beta blocker use

• Bronchial asthma

• Maternal or fetal indication for immediate delivery.